Thursday, March 28, 2024
ADVT 
National

Canadian vaccine maker touts promising results

Darpan News Desk The Canadian Press, 13 May, 2021 11:00 AM
  • Canadian vaccine maker touts promising results

A homegrown mRNA vaccine for COVID-19 shows promising results in its first small trial and its maker is hoping to test it directly against the vaccine from Pfizer-BioNTech.

Calgary-based Providence Therapeutics says its vaccine produced no serious adverse events and developed good antibodies against COVID-19 that "compare favourably" with the two mRNA vaccines already on the market from Pfizer and Moderna.

The Phase 1 trial included 60 healthy adults between 18 and 64, with more than half of them receiving two doses of the vaccine, four weeks apart. The results have not yet been peer-reviewed.

Providence Therapeutics CEO Brad Sorenson says the company is extremely pleased with the results but feels like it's not getting the support or recognition it deserves from Ottawa.

Sorenson says he needs 500 Pfizer doses to move to the Phase 2 head-to-head trial, but hasn't been able to get those doses from the company or Health Canada.

A spokesman for federal Innovation Minister François-Philippe Champagne says Providence has received almost $10 million in federal funding to date, and the company has been told Ottawa is also committed to supporting it through its Phase 2 trial.<

MORE National ARTICLES

Forces see little progress in drive to add women

Forces see little progress in drive to add women
Then-defence chief general Jonathan Vance in February 2016 set a goal of having women represent one-quarter of the Canadian Armed Forces' members over the next decade. At the time, women accounted for 15 per cent of military personnel.

Forces see little progress in drive to add women

Business leaders in U.S., Canada join Line 5 fight

Business leaders in U.S., Canada join Line 5 fight
The Canadian and U.S. chambers of commerce joined forces with their counterparts in Ohio, Michigan and Wisconsin by filing a joint brief in court to argue against Gov. Gretchen Whitmer's bid to shut down the cross-border pipeline.

Business leaders in U.S., Canada join Line 5 fight

Canada-U.S. spat over right whale prompts proposal

Canada-U.S. spat over right whale prompts proposal
A Canada-U.S. spat over who is responsible for the recent death of a critically endangered right whale has prompted a senior Canadian official to suggest there's got to be a better way of settling such disputes.

Canada-U.S. spat over right whale prompts proposal

Questions remain about AstraZeneca shot's future

Questions remain about AstraZeneca shot's future
Questions remained Wednesday about the future of the Oxford-AstraZeneca vaccine in Canada as the federal government prepared to receive hundreds of thousands of doses while provinces limited use of the shot.

Questions remain about AstraZeneca shot's future

600 COVID19 cases for Wednesday

600 COVID19 cases for Wednesday
British Columbia is now pausing the first dose AstraZeneca program. “Given the limited availability of the AstraZeneca vaccine supply, we are holding all remaining AstraZeneca vaccine for dose-two booster immunizations. Existing pharmacy bookings will proceed."

600 COVID19 cases for Wednesday

B.C. expecting more AstraZeneca vaccine: minister

B.C. expecting more AstraZeneca vaccine: minister
Dix says a "significant amount" of the COVID-19 vaccine was also made available in the last week in the Island and Interior health regions.

B.C. expecting more AstraZeneca vaccine: minister